🇺🇸 FDA
Patent

US 11654182

Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K38/09A61K38/22

Quick answer

US patent 11654182 (Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/09, A61K38/22, A61K9/0009, A61K9/0019